Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
155 EUR | -0,45% |
|
-.--% | +8,43% |
01/07 | Dawn Health e Merck collaborano per supportare la cura dei Disturbi della Crescita | CI |
27/06 | Contratto collettivo dei chimici: Giorni di bonus per i membri del sindacato | DP |
Attività
- soluzioni e prodotti per la ricerca scientifica e biotecnologica (44,2%);
- prodotti farmaceutici (38,4%): farmaci da prescrizione per il trattamento di diabete, cancro, sclerosi multipla, infertilità, malattie cardiovascolari, disturbi del sistema nervoso centrale, disturbi infiammatori, ecc;
- materiali ad alte prestazioni per l'industria elettronica (17,4%): materiali semiconduttori, cristalli liquidi, pigmenti e additivi, materiali organici a base di carbonio, ecc.
Le vendite nette sono distribuite geograficamente come segue: Germania (4,8%), Europa (24%), Cina (12,9%), Asia/Pacifico (20,1%), Stati Uniti (26,8%), Nord America (1,6%), America Latina (6,3%), Medio Oriente e Africa (3,5%).
Numero di dipendenti: 62 345
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10,59% |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2,73% |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8,82% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6,20% |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2,70% |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6,65% |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12,10% |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7,31% |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7,83% |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3,68% |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13,51% |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2,38% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 63 | 13/07/20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/08/14 |
Director of Finance/CFO | 54 | 26/04/19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01/09/21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01/01/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01/05/12 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01/01/91 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01/01/95 |
Alexander Putz
BRD | Director/Board Member | 47 | 01/01/85 |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/08/23 |
Director/Board Member | - | 26/04/19 | |
Daniel Thelen
BRD | Director/Board Member | - | 26/04/19 |
Simon Thelen
BRD | Director/Board Member | 44 | 26/04/19 |
Birgit Biermann
BRD | Director/Board Member | 50 | 14/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
Azione B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
2 787 509 | 4.43% | 113 340 116 $ | |
PT MERCK TBK 86.65% | 388 194 920 | 86.65% | 96 272 340 $ |
VERA THERAPEUTICS, INC. 3.48% | 1 913 501 | 3.48% | 72 693 903 $ |
PRECIGEN, INC. 8.18% | 20 647 152 | 8.18% | 28 906 013 $ |
Coordinate società
![Indirizzo Merck KGaA(MRCK)](https://cdn.zonebourse.com/static/address/35806819.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
Ridgefield Holdco SARL
| |
Lamberts Healthcare Ltd.
![]() Lamberts Healthcare Ltd. Food RetailRetail Trade Part of Procter & Gamble Co., Lamberts Healthcare Ltd. is a leading supplier of vitamins, supplements, minerals, and nutritional supplements. The company was founded in 1982 and is based in Tunbridge Wells, UK. Lamberts ensures the quality of its products by including a best before end (BBE) date on all labels, which is based on extensive testing and supported by valid scientific rationale. The products maintain the nutrient levels detailed on the label until the BBE date, with a few percent difference permitted each way. Although supplements rarely become unsafe after the BBE date, they may become less potent due to the natural process of nutrient degradation. |
Food Retail
|
Millipore SAS
![]() Millipore SAS Electronic Equipment/InstrumentsElectronic Technology Founded in 1972, Millipore SAS is a subsidiary of Merck KGaA that provides industrial instruments for measurement. The company is based in Molsheim, France. |
Electronic Equipment/Instruments
|
Sigma-Aldrich Pte Ltd.
![]() Sigma-Aldrich Pte Ltd. Chemicals: SpecialtyProcess Industries Part of Merck KGaA, Sigma-Aldrich Pte Ltd. is a Singaporean company that manufactures and supplies biochemical and organic chemical products. The company is located in Singapore. |
Chemicals: Specialty
|
Merck SA
![]() Merck SA Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Merck SA is a Colombian company that manufactures pharmaceutical and chemical products. The company is based in Bogota, Colombia. |
Pharmaceuticals: Other
|
Merck Capital Ltd.
| |
Merck Invest SCS
| |
Merck Display Technologies Ltd.
| |
Merck Finance II SARL
|
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+22,78% | 9,56 Mrd | |
+30,09% | 4,85 Mrd | |
-21,31% | 4,48 Mrd | |
+24,78% | 3,9 Mrd | |
+11,03% | 2,01 Mrd | |
-2,11% | 1,99 Mrd | |
-36,28% | 1,89 Mrd | |
-43,19% | 1,77 Mrd | |
-0,50% | 1,64 Mrd |
- Borsa valori
- Azioni
- Azione MRK
- Azione MRCK
- Società Merck KGaA